arm targeting cancer biomarker her2 (Rockland Immunochemicals)
Rockland Immunochemicals is a verified supplier 
90
Structured Review
Rockland Immunochemicals
arm targeting cancer biomarker her2
Arm Targeting Cancer Biomarker Her2, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 90/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/node/Recombinant+Anti-HER2+Fab+antibody/pmc06910624-10-31-2
Average 90 stars, based on 3 article reviews
Arm Targeting Cancer Biomarker Her2, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 90/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/node/Recombinant+Anti-HER2+Fab+antibody/pmc06910624-10-31-2
Average 90 stars, based on 3 article reviews
arm targeting cancer biomarker her2 - by Bioz Stars,
2026-11
90/100 stars
Images
1) Product Images from "Advancing Targeted Radionuclide Therapy Through the National Cancer Institute’s Small Business Innovation Research Pathway"
Article Title: Advancing Targeted Radionuclide Therapy Through the National Cancer Institute’s Small Business Innovation Research Pathway
Journal: Journal of Nuclear Medicine
doi: 10.2967/jnumed.118.214684
Figure Legend Snippet: NCI SBIR–Funded TRT Contracts for 2015
Techniques Used: In Vitro, In Vivo, Marker, Fluorescence, Drug discovery, Imaging
Figure Legend Snippet: NCI SBIR–Funded TRT Contracts from 2016 to 2017
Techniques Used: Radioactivity, Drug discovery, Recombinant, Biomarker Discovery, In Vivo, Fluorescence, Binding Assay, Labeling, In Vitro, Produced, Software
Related Articles
Incubation:Article Title: Methods and compositions using peptides and proteins with C-terminal elements Article Snippet: .. For the standard curve, microtiter wells coated with 5 μg/ml rabbit anti-human IgG (SouthernBiotech) were incubated with a mixture of various concentrations of Article Title: Methods and compositions using peptides and proteins with c-terminal elements Article Snippet: .. For the standard curve, microtiter wells coated with 5 μg/ml rabbit anti-human IgG (SouthernBiotech) were incubated with a mixture of various concentrations of Article Title: Methods and compositions using peptides and proteins with C-terminal elements Article Snippet: .. For the standard curve, microtiter wells coated with 5 μg/ml rabbit anti-human IgG (SouthernBiotech) were incubated with a mixture of various concentrations of Concentration Assay:Article Title: Methods and compositions using peptides and proteins with C-terminal elements Article Snippet: .. For the standard curve, microtiter wells coated with 5 μg/ml rabbit anti-human IgG (SouthernBiotech) were incubated with a mixture of various concentrations of Article Title: Methods and compositions using peptides and proteins with c-terminal elements Article Snippet: .. For the standard curve, microtiter wells coated with 5 μg/ml rabbit anti-human IgG (SouthernBiotech) were incubated with a mixture of various concentrations of Article Title: Methods and compositions using peptides and proteins with C-terminal elements Article Snippet: .. For the standard curve, microtiter wells coated with 5 μg/ml rabbit anti-human IgG (SouthernBiotech) were incubated with a mixture of various concentrations of Recombinant:Article Title: Advancing Targeted Radionuclide Therapy Through the National Cancer Institute’s Small Business Innovation Research Pathway Article Snippet: 2016 , RadImmune, Inc. , Phase I , Metastatic melanoma , , Melanin , Conjugate 8C3 IgG with chelating agents to enable radiolabeling with α- and β-emitting therapeutic radionuclides; assess pharmacokinetics/pharmacodynamics and radiation dosimetry of radiolabeled 8C3 in murine and human melanoma models; perform proof-of-concept radioimmunotherapy experiments to assess efficacy and short-term toxicity. .. 2016 , Rockland Immunochemicals, Inc. , Phase I , HER2-positive cancers , 68 Ga and 177 Lu , HER2 and digoxigenin , Biomarker Discovery:Article Title: Advancing Targeted Radionuclide Therapy Through the National Cancer Institute’s Small Business Innovation Research Pathway Article Snippet: 2016 , RadImmune, Inc. , Phase I , Metastatic melanoma , , Melanin , Conjugate 8C3 IgG with chelating agents to enable radiolabeling with α- and β-emitting therapeutic radionuclides; assess pharmacokinetics/pharmacodynamics and radiation dosimetry of radiolabeled 8C3 in murine and human melanoma models; perform proof-of-concept radioimmunotherapy experiments to assess efficacy and short-term toxicity. .. 2016 , Rockland Immunochemicals, Inc. , Phase I , HER2-positive cancers , 68 Ga and 177 Lu , HER2 and digoxigenin , In Vivo:Article Title: Advancing Targeted Radionuclide Therapy Through the National Cancer Institute’s Small Business Innovation Research Pathway Article Snippet: 2016 , RadImmune, Inc. , Phase I , Metastatic melanoma , , Melanin , Conjugate 8C3 IgG with chelating agents to enable radiolabeling with α- and β-emitting therapeutic radionuclides; assess pharmacokinetics/pharmacodynamics and radiation dosimetry of radiolabeled 8C3 in murine and human melanoma models; perform proof-of-concept radioimmunotherapy experiments to assess efficacy and short-term toxicity. .. 2016 , Rockland Immunochemicals, Inc. , Phase I , HER2-positive cancers , 68 Ga and 177 Lu , HER2 and digoxigenin , Stability:Article Title: Advancing Targeted Radionuclide Therapy Through the National Cancer Institute’s Small Business Innovation Research Pathway Article Snippet: 2016 , RadImmune, Inc. , Phase I , Metastatic melanoma , , Melanin , Conjugate 8C3 IgG with chelating agents to enable radiolabeling with α- and β-emitting therapeutic radionuclides; assess pharmacokinetics/pharmacodynamics and radiation dosimetry of radiolabeled 8C3 in murine and human melanoma models; perform proof-of-concept radioimmunotherapy experiments to assess efficacy and short-term toxicity. .. 2016 , Rockland Immunochemicals, Inc. , Phase I , HER2-positive cancers , 68 Ga and 177 Lu , HER2 and digoxigenin , Fluorescence:Article Title: Advancing Targeted Radionuclide Therapy Through the National Cancer Institute’s Small Business Innovation Research Pathway Article Snippet: 2016 , RadImmune, Inc. , Phase I , Metastatic melanoma , , Melanin , Conjugate 8C3 IgG with chelating agents to enable radiolabeling with α- and β-emitting therapeutic radionuclides; assess pharmacokinetics/pharmacodynamics and radiation dosimetry of radiolabeled 8C3 in murine and human melanoma models; perform proof-of-concept radioimmunotherapy experiments to assess efficacy and short-term toxicity. .. 2016 , Rockland Immunochemicals, Inc. , Phase I , HER2-positive cancers , 68 Ga and 177 Lu , HER2 and digoxigenin , Affinity Purification:Article Title: Label free gravimetric detection of epidermal growth factor receptor by antibody immobilization on quartz crystal microbalance Article Snippet: An efficient and simple method for the detection of epidermal growth factor receptor (EGFR) using anti-EGFR immobilized quartz crystal microbalance (QCM) was developed.. The immobilization of antiEGFR on the gold surface of QCM electrode was constructed by a self-assembled monolayer (SAM) of thiosalicylic acid followed by the activation of 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS).. In order to assess the sensitivity of QCM, two analytical procedures namely, dip-and-dry and flow cell methods were investigated. |